Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 0

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Computational study for suppression of CD25/IL-2 interaction

Dehbashi, Moein, Hojati, Zohreh, Motovali-bashi, Majid, Ganjalikhani-Hakemi, Mazdak, Shimosaka, Akihiro, Cho, William C. · 2021 · Biological Chemistry

Abstract

Cancer recurrence presents a huge challenge in cancer patient management. Immune escape is a key mechanism of cancer progression and metastatic dissemination. CD25 is expressed in regulatory T (Treg) cells including tumor-infiltrating Treg cells (TI-Tregs). These cells specially activate and reinforce immune escape mechanism of cancers. The suppression of CD25/IL-2 interaction would be useful against Treg cells activation and ultimately immune escape of cancer. Here, software, web servers and databases were used, at which in silico designed small interfering RNAs (siRNAs), de novo designed peptides and virtual screened small molecules against CD25 were introduced for the prospect of eliminating cancer immune escape and obtaining successful treatment. We obtained siRNAs with low off-target effects. Further, small molecules based on the binding homology search in ligand and receptor similarity were introduced. Finally, the critical amino acids on CD25 were targeted by a de novo designed peptide with disulfide bond. Hence we introduced computational-based antagonists to lay a foundation for further in vitro and in vivo studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/hsz-2020-0326

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 67

  1. Al-Qahtani, D., Anil, S., and Rajendran, R. (2011). Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma. J. Oral Pathol. Med. 40: 636–642. https://doi.org/10.1111/j.1600-0714.2011.01020.x. · DOI
  2. Amor, K.T., Ryan, C., and Menter, A. (2010). The use of cyclosporine in dermatology: part I. J. Am. Acad. Dermatol. 63: 925–946. https://doi.org/10.1016/j.jaad.2010.02.063. · doi:10.1016/j.jaad.2010.02.063
  3. Arkin, M.R., Randal, M., DeLano, W.L., Hyde, J., Luong, T.N., Oslob, J.D., Raphael, D.R., Taylor, L., Wang, J., McDowell, R.S., et al.. (2003). Binding of small molecules to an adaptive protein-protein interface. Proc. Natl. Acad. Sci. U.S.A. 100: 1603–1608. https://doi.org/10.1073/pnas.252756299. · DOI · Paper page
  4. Bates, G.J., Fox, S.B., Han, C., Leek, R.D., Garcia, J.F., Harris, A.L., and Banham, A.H. (2006). Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24: 5373–5380. https://doi.org/10.1200/jco.2006.05.9584. · DOI · Paper page
  5. Blaszczyk, M., Kurcinski, M., Kouza, M., Wieteska, L., Debinski, A., Kolinski, A., and Kmiecik, S. (2016). Modeling of protein-peptide interactions using the CABS-dock web server for binding site search and flexible docking. Methods 93: 72–83. https://doi.org/10.1016/j.ymeth.2015.07.004. · DOI
  6. Chaudhary, B. and Elkord, E. (2016). Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting. Vaccines 4: 28. https://doi.org/10.3390/vaccines4030028. · DOI · Paper page
  7. Chernikov, I.V., Vlassov, V.V., and Chernolovskaya, E.L. (2019). Current development of siRNA bioconjugates: from research to the clinic. Front. Pharmacol. 10: 444. https://doi.org/10.3389/fphar.2019.00444. · DOI · Paper page
  8. Ciemny, M.P., Debinski, A., Paczkowska, M., Kolinski, A., Kurcinski, M., and Kmiecik, S. (2016). Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction. Sci. Rep. 6: 37532. https://doi.org/10.1038/srep37532. · DOI
  9. Ciemny, M.P., Kurcinski, M., Kozak, K.J., Kolinski, A., and Kmiecik, S. (2017). Highly flexible protein–peptide docking using CABS-dock. In: Modeling peptide–protein interactions. New York, NY: Humana Press, pp. 69–94. · DOI
  10. Coles, S.J., Hills, R.K., Wang, E.C.Y., Burnett, A.K., Man, S., Darley, R.L., and Tonks, A. (2012). Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells. Leukemia 26: 2146–2148. https://doi.org/10.1038/leu.2012.75. · doi:10.1038/leu.2012.75
  11. Curiel, T.J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J.R., Zhang, L., Burow, M., et al.. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942–949. https://doi.org/10.1038/nm1093. · DOI · Paper page
  12. Curti, A., Trabanelli, S., Onofri, C., Aluigi, M., Salvestrini, V., Ocadlikova, D., Evangelisti, C., Rutella, S., De Cristofaro, R., Ottaviani, E., et al. (2010). Indoleamine 2, 3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. Haematologica 95: 2022–2030. https://doi.org/10.3324/haematol.2010.025924. · DOI
  13. de Vries, S.J., Rey, J., Schindler, C.E., Zacharias, M., and Tuffery, P. (2017). The pepATTRACT web server for blind, large-scale peptide-protein docking. Nucl. Acids Res. 45: W361–W364. https://doi.org/10.1093/nar/gkx335. · DOI
  14. deLeeuw, R.J., Kost, S.E., Kakal, J.A., and Nelson, B.H. (2012). The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin. Canc. Res. 18: 3022–3029. https://doi.org/10.1158/1078-0432.ccr-11-3216. · DOI · Paper page
  15. Duell, J., Dittrich, M., Bedke, T., Mueller, T., Eisele, F., Rosenwald, A., Rasche, L., Hartmann, E., Dandekar, T., Einsele, H., et al. (2017). Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL. Leukemia 31: 2181–2190. https://doi.org/10.1038/leu.2017.41. · DOI · Paper page
  16. Dundas, J., Ouyang, Z., Tseng, J., Binkowski, A., Turpaz, Y., and Liang, J. (2006). CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucl. Acids Res. 34: W116–W118. https://doi.org/10.1093/nar/gkl282. · DOI · Paper page
  17. Ekins, S., Mestres, J., and Testa, B. (2007). In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br. J. Pharmacol. 152: 9–20. https://doi.org/10.1038/sj.bjp.0707305. · DOI · Paper page
  18. Gao, Q., Qiu, S.J., Fan, J., Zhou, J., Wang, X.Y., Xiao, Y.S., Xu, Y., Li, Y.W., and Tang, Z.Y. (2007). Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25: 2586–2593. https://doi.org/10.1200/jco.2006.09.4565. · DOI · Paper page
  19. Garcia-Garcia, J., Guney, E., Aragues, R., Planas-Iglesias, J., and Oliva, B. (2010). Biana: a software framework for compiling biological interactions and analyzing networks. BMC Bioinf. 11: 56. https://doi.org/10.1186/1471-2105-11-56. · DOI
  20. Garcia-Garcia, J., Valls-Comamala, V., Guney, E., Andreu, D., Muñoz, F.J., Fernandez-Fuentes, N., and Oliva, B. (2017). iFrag: a protein-protein interface prediction server based on sequence fragments. J. Mol. Biol. 429: 382–389. https://doi.org/10.1016/j.jmb.2016.11.034. · DOI
  21. Goodman, W.A., Cooper, K.D., and McCormick, T.S. (2012). Regulation generation: the suppressive functions of human regulatory T cells. Crit. Rev. Immunol. 32, https://doi.org/10.1615/critrevimmunol.v32.i1.40. · DOI
  22. Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G., and Linsley, P.S. (2003). Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21: 635–637. https://doi.org/10.1038/nbt831. · DOI · Paper page
  23. Jiang, Y., Du, Z., Yang, F., Di, Y., Li, J., Zhou, Z., Pillarisetty, V.G., and Fu, D. (2014). FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis. PLoS One 9: e106741. https://doi.org/10.1371/journal.pone.0106741. · DOI
  24. Jiménez-García, B., Pons, C., and Fernández-Recio, J. (2013). pyDockWEB: a web server for rigid-body protein-protein docking using electrostatics and desolvation scoring. Bioinformatics 29: 1698–1699. https://doi.org/10.1093/bioinformatics/btt262. · DOI · Paper page
  25. Kawabata, T. and Go, N. (2007). Detection of pockets on protein surfaces using small and large probe spheres to find putative ligand binding sites. Proteins 68: 516–529. https://doi.org/10.1002/prot.21283. · DOI
  26. Kindlund, B., Sjöling, Å., Yakkala, C., Adamsson, J., Janzon, A., Hansson, L.E., Hermansson, M., Janson, P., Winqvist, O., and Lundin, S.B. (2017). CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β. Gastric Cancer 20: 116–125. https://doi.org/10.1007/s10120-015-0591-z. · DOI
  27. Klebe, G. (2006). Virtual ligand screening: strategies, perspectives and limitations. Drug Discov. Today 11: 580–594. https://doi.org/10.1016/j.drudis.2006.05.012. · DOI · Paper page
  28. Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al.. (2010). DrugBank 3.0: a comprehensive resource for ’omics’ research on drugs. Nucl. Acids Res. 39: D1035–D1041.https://doi.org/10.1093/nar/gkq1126. · DOI · Paper page
  29. Kurcinski, M., Jamroz, M., Blaszczyk, M., Kolinski, A., and Kmiecik, S. (2015). CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucl. Acids Res. 43: W419–W424. https://doi.org/10.1093/nar/gkv456. · DOI · Paper page
  30. Scognamiglio, P.L., Di Natale, C., Perretta, G., and Marasco, D. (2013). From peptides to small molecules: an intriguing but intricated way to new drugs. Curr. Med. Chem. 20: 3803–3817. https://doi.org/10.2174/09298673113209990184. · DOI
  31. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A.C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al.. (2014). DrugBank 4.0: shedding new light on drug metabolism. Nucl. Acids Res. 42: D1091–D1097. https://doi.org/10.1093/nar/gkt1068. · DOI · Paper page
  32. Lee, G.R. (2017). Phenotypic and functional properties of tumor-infiltrating regulatory T cells. Mediat. Inflamm. 2017: 1–9, doi:https://doi.org/10.1155/2017/5458178. · DOI
  33. Leffers, N., Gooden, M.J., de Jong, R.A., Hoogeboom, B.N., Klaske, A., Hollema, H., Boezen, H.M., van der Zee, A.G., Daemen, T., and Nijman, H.W. (2009). Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Canc. Immunol. Immunother. 58: 449. https://doi.org/10.1007/s00262-008-0583-5. · DOI · Paper page
  34. Li, W. and Godzik, A. (2006). Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22: 1658–1659. https://doi.org/10.1093/bioinformatics/btl158. · DOI · Paper page
  35. Liang, Y.J., Liu, H.C., Su, Y.X., Zhang, T.H., Chu, M., Liang, L.Z., and Liao, G.Q. (2011). Foxp3 expressed by tongue squamous cell carcinoma cells correlates with clinicopathologic features and overall survival in tongue squamous cell carcinoma patients. Oral Oncol. 47: 566–570. https://doi.org/10.1016/j.oraloncology.2011.04.017. · DOI
  36. Lin, Y.C., Mahalingam, J., Chiang, J.M., Su, P.J., Chu, Y.Y., Lai, H.Y., Fang, J.H., Huang, C.T., Chiu, C.T., and Lin, C.Y. (2013). Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer. Int. J. Canc. 132: 1341–1350. https://doi.org/10.1002/ijc.27784. · DOI
  37. Litfin, T., Zhou, Y., and Yang, Y. (2017). SPOT-ligand 2: improving structure-based virtual screening by binding-homology search on an expanded structural template library. Bioinformatics 33: 1238–1240. https://doi.org/10.1093/bioinformatics/btw829. · DOI
  38. Naito, Y., Yamada, T., Ui-Tei, K., Morishita, S., and Saigo, K. (2004). siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res. 32: W124–W129. https://doi.org/10.1093/nar/gkh442. · DOI · Paper page
  39. Naito, Y., Yoshimura, J., Morishita, S., and Ui-Tei, K. (2009). siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect. BMC Bioinf. 10: 1–8. https://doi.org/10.1186/1471-2105-10-392. · DOI · Paper page
  40. Pellecchia, M. (2013). Antagonists of protein-protein interactions made easy? J. Med. Chem. 56: 13–14. https://doi.org/10.1021/jm301837n. · DOI
  41. Rickert, M., Wang, X., Boulanger, M.J., Goriatcheva, N., and Garcia, K.C. (2005). The structure of interleukin-2 complexed with its alpha receptor. Science 308: 1477–1480. https://doi.org/10.1126/science.1109745. · DOI · Paper page
  42. Robb, R.J., Rusk, C.M., and Neeper, M.P. (1988). Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis. Proc. Natl. Acad. Sci. U.S.A. 85: 5654–5658. https://doi.org/10.1073/pnas.85.15.5654. · DOI
  43. Sauve, K., Nachman, M., Spence, C., Bailon, P., Campbell, E., Tsien, W.H., Kondas, J.A., Hakimi, J., and Ju, G. (1991). Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor. Proc. Natl. Acad. Sci. U.S.A. 88: 4636–4640. https://doi.org/10.1073/pnas.88.11.4636. · DOI
  44. Sayour, E.J., McLendon, P., McLendon, R., De Leon, G., Reynolds, R., Kresak, J., Sampson, J.H., and Mitchell, D.A. (2015). Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Canc. Immunol. Immunother. 64: 419–427. https://doi.org/10.1007/s00262-014-1651-7. · DOI · Paper page
  45. Tao, H., Mimura, Y., Aoe, K., Kobayashi, S., Yamamoto, H., Matsuda, E., Okabe, K., Matsumoto, T., Sugi, K., and Ueoka, H. (2012). Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Canc. 75: 95–101. https://doi.org/10.1016/j.lungcan.2011.06.002. · DOI · Paper page
  46. Schindler, C.E., de Vries, S.J., and Zacharias, M. (2015). Fully blind peptide-protein docking with pepATTRACT. Structure 23: 1507–1515. https://doi.org/10.1016/j.str.2015.05.021. · DOI
  47. Schmidtke, P., Le Guilloux, V., Maupetit, J., and Tuffery, P. (2010). Fpocket: online tools for protein ensemble pocket detection and tracking. Nucl. Acids Res. 38: W582–W589. https://doi.org/10.1093/nar/gkq383. · DOI · Paper page
  48. Shah, W., Yan, X., Jing, L., Zhou, Y., Chen, H., and Wang, Y. (2011). A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+ FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell. Mol. Immunol. 8: 59–66. https://doi.org/10.1038/cmi.2010.56. · DOI · Paper page
  49. Shang, B., Liu, Y., Jiang, S.J., and Liu, Y. (2015). Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci. Rep. 5: 15179. https://doi.org/10.1038/srep15179. · DOI · Paper page
  50. Shimizu, J., Yamazaki, S., and Sakaguchi, S. (1999). Induction of tumor immunity by removing CD25+ CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163: 5211–5218. · DOI · Paper page
  51. Shirley, M. (2017). Daclizumab: a review in relapsing multiple sclerosis. Drugs 77: 447–458. https://doi.org/10.1007/s40265-017-0708-2. · DOI
  52. Shoichet, B.K. (2004). Virtual screening of chemical libraries. Nature 432: 862–865. https://doi.org/10.1038/nature03197. · DOI · Paper page
  53. Strauss, L., Bergmann, C., Gooding, W., Johnson, J.T., and Whiteside, T.L. (2007). The frequency and suppressor function of CD4+ CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin. Canc. Res. 13: 6301–6311. https://doi.org/10.1158/1078-0432.ccr-07-1403. · DOI · Paper page
  54. Tilley, J.W., Chen, L., Fry, D.C., Emerson, S.D., Powers, G.D., Biondi, D., Varnell, T., Trilles, R., Guthrie, R., Mennona, F., et al.. (1997). Identification of a small molecule inhibitor of the IL-2/IL-2R? receptor interaction which binds to IL-2. J. Am. Chem. Soc. 119: 7589–7590. https://doi.org/10.1021/ja970702x. · DOI
  55. Ui-Tei, K., Naito, Y., Nishi, K., Juni, A., and Saigo, K. (2008). Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect. Nucl. Acids Res. 36: 7100–7109. https://doi.org/10.1093/nar/gkn902. · DOI · Paper page
  56. Vagner, J., Qu, H., and Hruby, V.J. (2008). Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol. 12: 292–296. https://doi.org/10.1016/j.cbpa.2008.03.009. · DOI · Paper page
  57. Volkamer, A., Kuhn, D., Grombacher, T., Rippmann, F., and Rarey, M. (2012). Combining global and local measures for structure-based druggability predictions. J. Chem. Inf. Model. 52: 360–372. https://doi.org/10.1021/ci200454v. · DOI · Paper page
  58. Volkamer, A., Kuhn, D., Rippmann, F., and Rarey, M. (2012). DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 28: 2074–2075. https://doi.org/10.1093/bioinformatics/bts310. · DOI · Paper page
  59. Weiss, L., Melchardt, T., Egle, A., Grabmer, C., Greil, R., and Tinhofer, I. (2011). Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia. Cancer 117: 2163–2169. https://doi.org/10.1002/cncr.25752. · DOI
  60. Wishart, D.S., Feunang, Y.D., Guo, A.C., Lo, E.J., Marcu, A., Grant, J.R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al.. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucl. Acids Res. 46: D1074–D1082. https://doi.org/10.1093/nar/gkx1037. · DOI · Paper page
  61. Wishart, D.S., Knox, C., Guo, A.C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., and Hassanali, M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 36: D901–D906. https://doi.org/10.1093/nar/gkm958. · DOI · Paper page
  62. Kawabata, T. (2010). Detection of multiscale pockets on protein surfaces using mathematical morphology. Proteins 78: 1195–1211. https://doi.org/10.1002/prot.22639. · DOI · Paper page
  63. Wu, Z., Johnson, K.W., Goldstein, B., Choi, Y., Eaton, S.F., Laue, T.M., and Ciardelli, T.L. (1995). Solution assembly of a soluble, heteromeric, high affinity interleukin-2 receptor complex. J. Biol. Chem. 270: 16039–16044. https://doi.org/10.1074/jbc.270.27.16039. · DOI
  64. Yang, Y., Zhan, J., and Zhou, Y. (2016). SPOT-Ligand: fast and effective structure-based virtual screening by binding homology search according to ligand and receptor similarity. J. Comput. Chem. 37: 1734–1739. https://doi.org/10.1002/jcc.24380. · DOI
  65. Yang, Z.Z., Novak, A.J., Stenson, M.J., Witzig, T.E., and Ansell, S.M. (2006). Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639–3646. https://doi.org/10.1182/blood-2005-08-3376. · DOI · Paper page
  66. Yuan, X.L., Chen, L., Li, M.X., Dong, P., Xue, J., Wang, J., Zhang, T.T., Wang, X.A., Zhang, F.M., Ge, H.L., et al.. (2010). Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol. 134: 277–288. https://doi.org/10.1016/j.clim.2009.10.005. · DOI
  67. Zhou, Q., Munger, M.E., Highfill, S.L., Tolar, J., Weigel, B.J., Riddle, M., Sharpe, A.H., Vallera, D.A., Azuma, M., Levine, B.L., et al.. (2010). Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 116: 2484–2493. https://doi.org/10.1182/blood-2010-03-275446. · DOI · Paper page

Metadata

Authors
Dehbashi, M., Hojati, Z., Motovali-bashi, M., Ganjalikhani-Hakemi, M., Shimosaka, A., & Cho, W. C.
Venue
Biological Chemistry
Published
2020-11-19
Volume
402
Issue
2
Pages
167-178
ISSN
  • 1437-4315
  • 1431-6730
Cited by
0
References
1
Language
en
Funders
The Graduate Office of University of Isfahan (8489)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Computational study for suppression of CD25/IL-2 interaction. https://app.cochat.ai/papers/10.1515/hsz-2020-0326
The paper
Dehbashi, M., Hojati, Z., Motovali-bashi, M., Ganjalikhani-Hakemi, M., Shimosaka, A., & Cho, W. C. (2021). Computational study for suppression of CD25/IL-2 interaction. Biological Chemistry. https://doi.org/10.1515/hsz-2020-0326

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.